96 related articles for article (PubMed ID: 12745075)
1. Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant.
Yeh CT; Lu SC; Chao CH; Chao ML
Biochem Biophys Res Commun; 2003 May; 305(2):311-4. PubMed ID: 12745075
[TBL] [Abstract][Full Text] [Related]
2. Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.
Yeh CT; Lu SC; Chen TC; Peng CY; Liaw YF
Cancer Res; 2000 Sep; 60(17):4697-700. PubMed ID: 10987270
[TBL] [Abstract][Full Text] [Related]
3. KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases.
Hannon GJ; Casso D; Beach D
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1731-5. PubMed ID: 8127873
[TBL] [Abstract][Full Text] [Related]
4. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin.
Poon RY; Hunter T
Science; 1995 Oct; 270(5233):90-3. PubMed ID: 7569954
[TBL] [Abstract][Full Text] [Related]
5. Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2.
Chinami M; Yano Y; Yang X; Salahuddin S; Moriyama K; Shiroishi M; Turner H; Shirakawa T; Adra CN
J Biol Chem; 2005 Apr; 280(17):17235-42. PubMed ID: 15671017
[TBL] [Abstract][Full Text] [Related]
6. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
Song H; Hanlon N; Brown NR; Noble ME; Johnson LN; Barford D
Mol Cell; 2001 Mar; 7(3):615-26. PubMed ID: 11463386
[TBL] [Abstract][Full Text] [Related]
7. Purification and crystallization of the CDK-associated protein phosphatase KAP expressed in Escherichia coli.
Hanlon N; Barford D
Protein Sci; 1998 Feb; 7(2):508-11. PubMed ID: 9521129
[TBL] [Abstract][Full Text] [Related]
8. Human HTm4 is a hematopoietic cell cycle regulator.
Donato JL; Ko J; Kutok JL; Cheng T; Shirakawa T; Mao XQ; Beach D; Scadden DT; Sayegh MH; Adra CN
J Clin Invest; 2002 Jan; 109(1):51-8. PubMed ID: 11781350
[TBL] [Abstract][Full Text] [Related]
9. Generation of phosphorylated cyclin-dependent kinase 2 and functional characterization of threonine-160-specific phosphatase KAP.
Poon RY
Methods Enzymol; 1997; 283():283-92. PubMed ID: 9251027
[No Abstract] [Full Text] [Related]
10. The mechanism of protein kinase regulation by protein phosphatases.
Barford D
Biochem Soc Trans; 2001 Aug; 29(Pt 4):385-91. PubMed ID: 11497994
[TBL] [Abstract][Full Text] [Related]
11. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2.
Gyuris J; Golemis E; Chertkov H; Brent R
Cell; 1993 Nov; 75(4):791-803. PubMed ID: 8242750
[TBL] [Abstract][Full Text] [Related]
12. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
Brown NR; Noble ME; Lawrie AM; Morris MC; Tunnah P; Divita G; Johnson LN; Endicott JA
J Biol Chem; 1999 Mar; 274(13):8746-56. PubMed ID: 10085115
[TBL] [Abstract][Full Text] [Related]
13. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth.
Lin WR; Lai MW; Yeh CT
Oncol Rep; 2013 Mar; 29(3):903-10. PubMed ID: 23292002
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
16. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
17. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
18. Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma.
Yu Y; Jiang X; Schoch BS; Carroll RS; Black PM; Johnson MD
Cancer Res; 2007 Jan; 67(1):130-8. PubMed ID: 17210692
[TBL] [Abstract][Full Text] [Related]
19. Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor.
Kwon TK; Nordin AA
Oncogene; 1998 Feb; 16(6):755-62. PubMed ID: 9488039
[TBL] [Abstract][Full Text] [Related]
20. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression.
Sørensen CS; Lukas C; Kramer ER; Peters JM; Bartek J; Lukas J
Mol Cell Biol; 2001 Jun; 21(11):3692-703. PubMed ID: 11340163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
